Philips_logo_logotype_emblem-700x128.png
Philips delivers Q2 sales of EUR 4.2 billion, with 9% comparable sales growth; net income amounts to EUR 153 million and Adjusted EBITA margin improves 280 basis points to 12.6%; company announces EUR 1.5 billion share buyback program
July 26, 2021 01:00 ET | Royal Philips
July 26, 2021 Second-quarter highlights Group sales increased to EUR 4.2 billion, with 9% comparable sales growthComparable order intake decreased 15%, with strong double-digit growth in the...
Philips receives FDA Breakthrough Device Designation for laser-assisted IVC filter removal device
July 21, 2021 09:00 ET | Royal Philips
July 21, 2021 FDA Breakthrough Device Designation is granted to novel medical devices that have the potential to provide more effective treatmentIt is estimated that in the United States more than...
Philips and Cognizant collaborate to introduce digital health solutions to providers, researchers, and patients
July 08, 2021 09:00 ET | Royal Philips
Alliance Pairs Cloud-Based Healthcare Platform with Experience-Oriented Application Design to Improve Patient Care and Clinical Trials Through Increased Provider-Patient Connectivity AMSTERDAM,...
Philips accelerates stroke diagnosis and treatment with expanded integrated solutions and strategic partnership
July 07, 2021 04:05 ET | Royal Philips
July 7, 2021 Expanded capabilities of Philips Image Guided Therapy System – Azurion – and new collaboration with NICO.LAB add to the latest advances in Philips’ commitment to reduce time to...
Philips announces first patient enrolled in the WE-TRUST global multicenter stroke study to assess the impact of the Direct to Angio Suite workflow in improving patient outcomes
July 07, 2021 04:00 ET | Royal Philips
July 7, 2021 First patient enrolled in global multi-center randomized controlled trial with 564 patients at 15 sites comparing the impact of the Direct to Angio Suite workflow (diagnosis and...
Philips announces first patient treated with its new real-time 3D intracardiac echocardiography catheter – VeriSight Pro
July 01, 2021 09:00 ET | Royal Philips
July 01, 2021 FDA 510k-cleared real-time 3D intracardiac echocardiography (ICE) catheter has potential to improve standard of care for structural heart disease and electrophysiology procedures...
Philips and the Spanish National Center for Cardiovascular Research (CNIC) collaborate on a new ultra-fast cardiac MRI protocol for research purposes with the aim of benefitting clinical practice in the future
June 30, 2021 08:00 ET | Royal Philips
June 30, 2021 Ultra-fast, less than one-minute scan time, cardiac MRI enables accurate assessment of heart anatomy and function, improves patient comfort, increases access to care, and reduces...
Thomson Rogers And Rice Harbut Elliott LLP Have Jointly Issued A National Class Action On Behalf of All Persons in Canada Who Used A Philips CPAP Machine, BIPAP Machine Or Mechanical Ventilator Currently Subject To Recall.
June 28, 2021 10:00 ET | Thomson Rogers
Toronto, ON, June 28, 2021 (GLOBE NEWSWIRE) -- Thomson Rogers and Rice Harbut Elliott LLP have jointly issued a national class action on behalf of all persons in Canada who used a Philips CPAP...
Philips announces first patient enrollment in DEFINE GPS global multicenter study to assess superiority of PCI procedures guided by co-registered iFR and interventional angiography
June 22, 2021 09:00 ET | Royal Philips
June 22, 2021 First patient enrolled in global randomized controlled trial with up to 3,200 participants at 100 sites comparing patient outcomes after percutaneous coronary intervention (PCI)...
Philips_logo_logotype_emblem-700x128.png
Philips issues recall notification* to mitigate potential health risks related to the sound abatement foam component in certain sleep and respiratory care devices
June 14, 2021 01:00 ET | Royal Philips
June 14, 2021 Philips is initiating a voluntary recall notification* to ensure patient safety in consultation with regulatory agenciesCorrective actions include the deployment of updated instructions...